| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| 1 day | +7.19% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 31/12/2025 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 31/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 31/08/2022 |
| Director/Board Member | 63 | 18/06/2021 | |
Vadims Telica
BRD | Director/Board Member | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/08/21 | Sell | Chief Financial Officer | 97,424 | 0.6917% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.19% | +2.67% | - | - | 148M | |
| -0.85% | +0.30% | +14.56% | +76.15% | 48.41B | |
| +2.20% | +1.41% | +61.04% | +111.43% | 34.99B | |
| +1.87% | +0.04% | -4.62% | +35.30% | 11.62B | |
| -0.38% | -2.97% | +14.25% | +80.79% | 11.47B | |
| -1.68% | -0.19% | +36.83% | +136.73% | 8.99B | |
| +1.52% | +0.39% | +48.79% | -5.82% | 6.88B | |
| +0.43% | -2.34% | +13.81% | +31.24% | 6.62B | |
| -0.46% | -1.84% | +2.34% | +178.37% | 6.43B | |
| +1.60% | -15.49% | -29.66% | +8.47% | 5.75B | |
| Average | +1.15% | -1.88% | +17.48% | +72.52% | 15.69B | |
| Weighted average by Cap. | +0.43% | -1.08% | +25.17% | +81.56% |
Employees
2,191
Sector
Pharmaceuticals
